X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (82425) 82425
Book Review (16977) 16977
Publication (5180) 5180
Newsletter (4678) 4678
Conference Proceeding (718) 718
Book Chapter (269) 269
Book / eBook (133) 133
Newspaper Article (106) 106
Magazine Article (88) 88
Dissertation (69) 69
Reference (19) 19
Web Resource (19) 19
Transcript (14) 14
Journal / eJournal (8) 8
Presentation (8) 8
Trade Publication Article (8) 8
Government Document (7) 7
Data Set (3) 3
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (67186) 67186
humans (66312) 66312
female (46392) 46392
oncology (37184) 37184
middle aged (33790) 33790
chemotherapy, adjuvant (33117) 33117
cancer (32072) 32072
aged (28598) 28598
male (28054) 28054
adult (26505) 26505
chemotherapy (22618) 22618
treatment outcome (18990) 18990
surgery (18484) 18484
adjuvant treatment (17227) 17227
prognosis (16483) 16483
neoplasm staging (16108) 16108
breast cancer (15938) 15938
adjuvant chemotherapy (15862) 15862
antineoplastic combined chemotherapy protocols - therapeutic use (15598) 15598
care and treatment (13719) 13719
retrospective studies (12135) 12135
radiotherapy (12054) 12054
combined modality therapy (11991) 11991
radiotherapy, adjuvant (11861) 11861
research (11841) 11841
survival (11496) 11496
breast neoplasms - drug therapy (11253) 11253
aged, 80 and over (10782) 10782
disease-free survival (9469) 9469
survival rate (8997) 8997
follow-up studies (8931) 8931
carcinoma (8865) 8865
therapy (8372) 8372
health aspects (8367) 8367
analysis (8362) 8362
medicine & public health (8030) 8030
breast neoplasms - pathology (7995) 7995
survival analysis (7614) 7614
antineoplastic agents - therapeutic use (7579) 7579
neoadjuvant therapy (7477) 7477
risk factors (6922) 6922
abridged index medicus (6403) 6403
tumors (6318) 6318
oncology, experimental (6047) 6047
radiation-therapy (5442) 5442
metastasis (5424) 5424
hematology, oncology and palliative medicine (5310) 5310
time factors (5217) 5217
lymphatic metastasis (5076) 5076
women (4901) 4901
adolescent (4894) 4894
breast neoplasms - surgery (4812) 4812
adjuvant therapy (4770) 4770
colorectal cancer (4596) 4596
cancer patients (4588) 4588
animals (4523) 4523
trial (4508) 4508
prospective studies (4448) 4448
randomized-trial (4320) 4320
fluorouracil - administration & dosage (4305) 4305
patient outcomes (4140) 4140
neoadjuvant chemotherapy (4096) 4096
recurrence (4063) 4063
drug therapy (4008) 4008
young adult (3852) 3852
antineoplastic combined chemotherapy protocols - adverse effects (3800) 3800
radiology, nuclear medicine & medical imaging (3781) 3781
kaplan-meier estimate (3755) 3755
radiation (3737) 3737
cisplatin - administration & dosage (3603) 3603
obstetrics & gynecology (3600) 3600
patients (3531) 3531
breast neoplasms - therapy (3511) 3511
diagnosis (3427) 3427
adenocarcinoma (3412) 3412
randomized controlled trials as topic (3368) 3368
cisplatin (3362) 3362
breast neoplasms - mortality (3356) 3356
multivariate analysis (3342) 3342
cancer therapies (3296) 3296
radiation therapy (3284) 3284
fluorouracil (3250) 3250
clinical trials (3242) 3242
proportional hazards models (3233) 3233
management (3230) 3230
neoplasm recurrence, local (3228) 3228
immunohistochemistry (3222) 3222
antineoplastic combined chemotherapy protocols - administration & dosage (3078) 3078
child (3065) 3065
tamoxifen (3045) 3045
medical research (2995) 2995
adjuvant (2967) 2967
gastroenterology & hepatology (2962) 2962
clinical trials as topic (2913) 2913
medicine, general & internal (2764) 2764
drug administration schedule (2759) 2759
risk assessment (2741) 2741
risk (2716) 2716
trastuzumab (2699) 2699
radiotherapy dosage (2685) 2685
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (97) 97
Online Resources - Online (17) 17
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Gerstein Science - Periodical Stacks (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Gerstein Science - Bindery (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Media Commons - Audio Visual (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (79617) 79617
German (2102) 2102
French (1793) 1793
Japanese (1656) 1656
Chinese (623) 623
Russian (497) 497
Spanish (406) 406
Italian (330) 330
Polish (196) 196
Hungarian (180) 180
Dutch (78) 78
Korean (68) 68
Danish (64) 64
Portuguese (63) 63
Czech (50) 50
Turkish (42) 42
Romanian (37) 37
Bulgarian (29) 29
Norwegian (25) 25
Ukrainian (23) 23
Finnish (18) 18
Swedish (18) 18
Hebrew (13) 13
Lithuanian (13) 13
Icelandic (7) 7
Serbian (7) 7
Slovak (6) 6
Croatian (4) 4
Slovenian (2) 2
Arabic (1) 1
Catalan (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chemotherapy, ISSN 1421-9794, 1968
Journal
Cancer, ISSN 0008-543X, 07/2012, Volume 118, Issue 13, pp. 3377 - 3386
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2010, Volume 119, Issue 2, pp. 212 - 216
Journal Article
JAMA, ISSN 0098-7484, 11/2016, Volume 316, Issue 18, pp. 1888 - 1896
IMPORTANCE: Standard dosing of chemotherapy based on body surface area results in marked interpatient variation in pharmacokinetics, toxic effects, and... 
MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | THERAPY | EUROPEAN-ORGANIZATION | CMF | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Epirubicin - administration & dosage | Austria | Sweden | Fluorouracil - administration & dosage | Antineoplastic Agents - adverse effects | Chemotherapy, Adjuvant - adverse effects | Adult | Female | Drug Administration Schedule | Neoplasm Recurrence, Local | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Quality of Life | Breast Neoplasms - mortality | Aged | Germany | Women | Chemotherapy | Usage | Adjuvant treatment | Clinical trials | Breast cancer | Diagnosis | Research | Comparative analysis | Health aspects | Cancer | Womens health | Risk factors | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
2009, ISBN 0470092556, x, 341
Book
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3138 - 3145
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2010, Volume 46, Issue 13, pp. 2422 - 2431
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 687 - 697
Summary Background Trastuzumab, a monoclonal antibody against human epidermal growth factor receptor 2 (HER2; also known as ERBB2), was investigated in... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | SUPPORTIVE CARE | MEDICINE, GENERAL & INTERNAL | METASTATIC BREAST-CANCER | ADVANCED ESOPHAGOGASTRIC CANCER | GENE AMPLIFICATION | 1ST-LINE THERAPY | HER2 | FLUOROURACIL | III TRIAL | PLUS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Capecitabine | Humans | Middle Aged | Stomach Neoplasms - metabolism | Male | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Antibodies, Monoclonal, Humanized | Adenocarcinoma - metabolism | Fluorouracil - administration & dosage | Female | Drug Therapy, Combination | Receptor, ErbB-2 - biosynthesis | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Esophagogastric Junction | Antibodies, Monoclonal - administration & dosage | Survival Analysis | Aged | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Trastuzumab | Adenocarcinoma - mortality | Chemotherapy | Gastrointestinal cancer | Patient outcomes | Drug therapy, Combination | Drug therapy | Methods | Cancer | Voice recognition | Heart failure | Clinics | Heart attacks | Breast cancer | Blood pressure | Clinical medicine | Angina pectoris | Cancer therapies | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Annals of Surgery, ISSN 0003-4932, 11/2013, Volume 258, Issue 5, pp. 731 - 742
OBJECTIVES:We analyzed the impact of chemotherapy-related liver injuries (CALI), pathological tumor regression grade (TRG), and micrometastases on long-term... 
Neoadjuvant chemotherapy | Adjuvant chemotherapy | Tumor regression grade | Chemotherapy-related liver injuries | Sinusoidal dilatation | Sinusoidal obstruction syndrome | Colorectal liver metastases | Liver surgery | Survival | Preoperative chemotherapy | Prognostic factors | Steatosis | Microscopic biliary invasion | Body mass index | Nodular regenerative hyperplasia | Long-term outcome | Micrometastases | Pathological tumor response to chemotherapy | Steatohepatitis | Microvascular invasion | SURGERY | adjuvant chemotherapy | RECEIVING PREOPERATIVE CHEMOTHERAPY | sinusoidal obstruction syndrome | microvascular invasion | colorectal liver metastases | prognostic factors | OXALIPLATIN | tumor regression grade | CANCER | microscopic biliary invasion | preoperative chemotherapy | INTRAHEPATIC MICROMETASTASES | nodular regenerative hyperplasia | steatosis | steatohepatitis | HEPATECTOMY | body mass index | micrometastases | pathological tumor response to chemotherapy | survival | liver surgery | HEPATIC RESECTION | chemotherapy-related liver injuries | sinusoidal dilatation | neoadjuvant chemotherapy | long-term outcome | BODY-MASS INDEX | CARCINOMA | Prognosis | Humans | Male | Fatty Liver - chemically induced | Bevacizumab | Neoplasm Micrometastasis | Antineoplastic Agents - adverse effects | Female | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Hepatectomy - methods | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Survival Rate | Treatment Outcome | Combined Modality Therapy | Hepatic Veno-Occlusive Disease - chemically induced | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
Summary Background Previous trials from our group suggested an overall survival benefit with five cycles of adjuvant full-dose epirubicin plus ifosfamide in... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer | Index Medicus
Journal Article